ArticleCardio-oncology (London, England)2026
Exploring healthcare professionals' experiences and perceptions of self-management of cancer therapy-induced cardiotoxicity in breast cancer survivors: a qualitative study.
Article in Cardio-oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveAdvancements in cancer treatments have significantly improved survival rates for breast cancer (BC) patients; however, these treatments are often accompanied by severe adverse effects, such as cardiotoxicity. Effective patient-centred self-management plays a critical role in the early detection of cardiotoxic symptoms and in enhancing BC survivors’ overall quality of life. To support this process, education and ongoing support from healthcare professionals is essential. This study aimed to explore healthcare professionals’ experiences and perspectives in facilitating BC survivors’ self-management of cancer therapy-induced cardiotoxicity.
methodsThis study employed a fundamental qualitative descriptive approach. Semi-structured interviews were conducted with healthcare professionals from a BC department in Guangzhou, China. Audio recordings were transcribed and analysed using NVivo 12 software. Thematic analysis was also conducted.
findingsThirteen participants – including doctors, nurses, and a case manager – were recruited. The participants’ working experience ranged from two to 30 years. Three themes and six subthemes were identified: (1) healthcare professionals’ understanding of cancer therapy-induced cardiotoxicity and the importance of patients’ self-management of its symptoms; (2) strategies for supporting self-management; and (3) barriers and challenges to effective self-management, such as inefficient communication, low patient adherence, inadequate cross-departmental collaboration, and an outdated clinical system. Many of the participants relied more on pharmacological interventions than on empowering patients’ self-management skills.
conclusionsDespite healthcare professionals recognising the value of patients’ self-management of symptoms, multiple barriers hinder its implementation. Participants highlighted the need for more accessible, structured patient education approaches, as well as improvements to clinical information systems to better support ongoing monitoring and communication. Strengthening interdisciplinary collaboration and enhancing healthcare professionals’ training in self-management support were also identified as priorities for improving comprehensive cardio-oncology care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.